Research Keyword: psilocybin dosing

Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial

Researchers conducted a small pilot study examining whether psilocybin (the active compound in certain mushrooms) combined with therapy could help treat fibromyalgia, a chronic pain condition. Five participants received two doses of psilocybin along with supportive therapy sessions. The treatment was well-tolerated with only minor side effects, and participants reported significant improvements in pain, sleep quality, and overall functioning. These promising preliminary results suggest larger studies should be conducted to further test this innovative treatment approach.

Read More »

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

This study explored how patients with severe depression that didn’t respond to typical treatments experienced psilocybin therapy. Researchers interviewed 11 patients about their experiences and found that building trust with therapists, managing expectations, and having multiple treatment sessions were crucial. Many patients found the experience intense and overwhelming, and most wanted ongoing support to understand what they experienced and how it affected their recovery.

Read More »

Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder

Researchers tested whether watching nature videos during psilocybin therapy could improve treatment for alcohol addiction. Twenty participants received psilocybin sessions while either watching nature videos or using standard procedures with eyeshades and music. The study found that nature videos significantly reduced the blood pressure increases that normally occur with psilocybin, while maintaining the same therapeutic benefits for reducing alcohol use and promoting meaningful experiences.

Read More »
Scroll to Top